IDO is a nodal pathogenic driver of lung cancer and metastasis development

C Smith, MY Chang, KH Parker, DW Beury… - Cancer discovery, 2012 - AACR
… IDO activity profoundly influences the pathogenic character of the tumor
microenvironment by identifying the cytokine IL-6 as a crucial IDO effector for establishing “cancer-associated” …

Allelic losses at chromosome 8p21–23 are early and frequent events in the pathogenesis of lung cancer

II Wistuba, C Behrens, AK Virmani, S Milchgrub, S Syed… - Cancer research, 1999 - AACR
lung tumors (22 small cell lung carcinomas, 25 squamous cell carcinomas, and 21
adenocarcinomas). We also studied the role of 8p deletions in lung cancer pathogenesis by … cell …

Molecular pathogenesis of hereditary lung cancer: A literature review

S Rammal, HR Kourie, N Jalkh, C Mehawej… - …, 2021 - Taylor & Francis
… , and expose germline mutations that are linked to this type of cancer. We also report
pathogenic genetic variants linked to syndromes associated with lung cancer. …

Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update

KM Antoniou, S Tomassetti, E Tsitoura… - Current opinion in …, 2015 - journals.lww.com
LUNG CANCER PATHOGENESIS: EPIGENETIC UPDATE Common pathogenic concepts in
IPF and lung cancer … alterations involved in the pathogenesis of IPF and cancer. Epigenetic …

Microbiome dysbiosis and epigenetic modulations in lung cancer: from pathogenesis to therapy

FH Khan, BA Bhat, BA Sheikh, L Tariq… - Seminars in Cancer …, 2022 - Elsevier
… This review highlights the recent studies that address the causal link between the microbiome
and lung cancer. Furthermore, we discuss the epigenetic changes underlying lung cancer

Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer

L Prudkin, C Behrens, DD Liu, X Zhou, NC Ozburn… - Clinical cancer …, 2008 - AACR
… Fus1 expression in lung cancer pathogenesis and progression… tissue specimens and
adjacent lung bronchial and alveolar … the clinicopathologic features of patients with lung cancer. …

[HTML][HTML] CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer

J Zhu, Y Zeng, W Li, H Qin, Z Lei, D Shen, D Gu… - Molecular cancer, 2017 - Springer
… underexpressed in non-small cell lung cancer tissues compared with adjacent noncancerous.
… We also found that overexpression of miR-30a-5p in these non-small cell lung cancer cell …

Updates on the pathogenesis of advanced lung cancer‐induced cachexia

R Zhu, Z Liu, R Jiao, C Zhang, Q Yu, S Han… - … cancer, 2019 - Wiley Online Library
… The present article summarizes the pathogenesis of advanced lung cancer-… pathogenesis
to improve the quality of life and survival rate of cachectic patients with advanced lung cancer

Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases

MO Oyewumi, A Alazizi, D Wehrung… - … Journal of Cell …, 2014 - Wiley Online Library
… Thus, in this report, we will assess the data on lung cancer bone metastases with the
intention of evaluating key molecular targets that could be applied in optimizing lung cancer

[HTML][HTML] Potential micronutrients and phytochemicals against the pathogenesis of chronic obstructive pulmonary disease and lung cancer

T Zhai, S Li, W Hu, D Li, S Leng - Nutrients, 2018 - mdpi.com
Lung cancer and chronic obstructive pulmonary disease … epigenetics change) and lung
function impairment. Focusing on … to lung function preservation and prevention of lung cancer risk…